Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Aflibercept 30.1mg/263microlitres solution for injection vials |
| Virtual Therapeutic Moiety | Aflibercept |
| Abbreviated name | Aflibercept 30.1mg/263microlitres inj vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 263.000 |
| Unit dose form units | microlitre |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Aflibercept |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 114.300 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intravitreal |
| Dose Form | |
| Formulation | Solution for injection |
| Drug Route | |
| Route | Intravitreal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Eylea 30.1mg/263microlitres solution for injection vials (Bayer Plc) | |
| Virtual Medicinal Product Packs | |
| Aflibercept 30.1mg/263microlitres solution for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.